Skip to main content

Peer Review reports

From: CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy

Original Submission
11 Jun 2019 Submitted Original manuscript
12 Sep 2019 Reviewed Reviewer Report - Coy Heldermon
19 Oct 2019 Reviewed Reviewer Report - Xiaosong Chen
6 Nov 2019 Author responded Author comments - Wilson Eduardo Furlan Matos Alve
Resubmission - Version 2
6 Nov 2019 Submitted Manuscript version 2
9 Nov 2019 Reviewed Reviewer Report - Xiaosong Chen
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
11 Nov 2019 Editorially accepted
3 Dec 2019 Article published 10.1186/s12885-019-6353-2

You can find further information about peer review here.

Back to article page